Citius Pharmaceuticals, Inc. (CTXR) vs Vyome Holdings, Inc. (HIND)
- Citius Pharmaceuticals, Inc. CTXR 0.46 0.00%
- Vyome Holdings, Inc. HIND 1.87 −2.09%
Citius Pharmaceuticals, Inc. and Vyome Holdings, Inc. are both Biotechnology companies. Citius Pharmaceuticals, Inc. and Vyome Holdings, Inc. are of similar size ($13.4M and $12.6M). Citius Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Vyome Holdings, Inc. trades at 0.0×. Citius Pharmaceuticals, Inc. has the higher net margin (0.00% vs −8,711.7%) and the lower return on invested capital (−58.7% vs 0.00%). Across the 14 metrics below, Citius Pharmaceuticals, Inc. leads on 7 and Vyome Holdings, Inc. on 7.
Valuation
Profitability
| Metric | CTXR | HIND | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 52.77% | 65.16% |
| Operating margin | 0.00% | (9,184.82%) | 0.00% |
| Net margin | 0.00% | (8,711.71%) | 0.00% |
| Free cash flow margin | 0.00% | (4,298.00%) | 0.00% |
| Return on equity | (64.51%) | (172.10%) | (56.36%) |
| Return on assets | (34.29%) | (124.23%) | (48.04%) |
| Return on invested capital | (58.74%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack